Ferring Pharmaceuticals opened its Asia Pacific headquarter in Singapore in March 2016. Ferring Asia Pacific operations span across diverse geographies encompassing Australia, China, Hong Kong, India, Indonesia, Japan, Malaysia, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Since 2022, the Singapore regional office is also responsible for operations across Middle East and Africa countries. Ferring has been present in the region for over 30 years and currently employs over 1,200 employees across the markets.

Our Singapore regional headquarter has strategic oversight and executive management responsibilities over the company’s regional entities and activities in Asia Pacific, Middle East and Africa – a region highly recognized for fast growth and future talent and product development for Ferring. The headquarter facilitates collaboration across various operational disciplines and bring functions such as clinical development, supply chain planning and coordination, intellectual property management, legal, compliance, information technology, business development and licensing, product marketing, commercial excellence, quality assurance, regulatory affairs, and medical affairs together to support the countries where Ferring operates in.

Ferring is keen to establish partnerships with governments, healthcare institutions and universities to conduct research and development in the company’s prioritized disease areas and those of relevance to the Asia Pacific, Middle East and Africa countries. At Ferring, we are committed to helping people become parents and keeping mothers and babies healthy, from conception to birth. Over one third of our research and development investment goes towards finding innovative treatments in reproductive medicine and maternal health. We are also passionate about making a difference to people’s health and quality of life through our work in gastroenterology, urology, and uro-oncology.